From: Bench-to-bedside review: Sepsis - from the redox point of view
 | Patient groups |  | Method | Reference |
---|---|---|---|---|
Anti-oxidant | Â | Â | Â | Â |
   Ascorbate (mg/L) | Control: 1.71 ± 0.46 | Sepsis: 0.55 ± 0.28 | Spectrophotometric assay | [116] |
 | Control: 4.5 to 12 | Critically injured: 1.1 ± 0.3 | HPLC | [117] |
   Retinol (μg/L) | Control: 735 ± 183 | Septic shock: 265 ± 193 | HPLC | [118] |
   Tocopherol (mg/L) | Control: 11.5 ± 1.3 | Septic shock: 3.6 ± 2.0 | HPLC | [118] |
   β-Carotene (μg/L) | Control: 619 ± 259 | Septic shock: <101 | HPLC | [118] |
   Lycopene (μg/L) | Control: 522 ± 184 | Septic shock: <154 | HPLC | [118] |
Oxidative stress biomarkers | Â | Â | Â | Â |
   Total plasma thiols (R-SH) (μmol/L) | Control: 364 ± 22 | Sepsis: 138 ± 14 | Ellman's method | [119] |
   Lipid peroxidation (μmol/L) | Control: <2 | Patients with >3 failing organs: 4.9 ± 2.3 | TBARS assay | [118] |
 | Control: 0.92 ± 0.39 | Sepsis survivors: 0.99 ± 0.14 | TBARS assay | [120] |
 |  | Sepsis non-survivors: 3.33 ± 2.29 |  |  |
   Lipid peroxidation (nmol/mg of protein) | Sepsis (day 1): 2.4 | Sepsis (day 7): 2.9 | FOX assay | [121] |
   Total anti-oxidant capacity (nmol/mg of protein)a | Sepsis (day 1): 1.5 | Sepsis (day 7): 1.1 | ABTS assay | [121] |
   Total anti-oxidant capacity (%) | Control: 57.3 to 60.3 | Survivors: 51.4 to 55.4 | ABTS assay | [30] |
 |  | Non-survivors: 46.1 to 47.6 |  |  |
   Total anti-oxidant capacity (μmol/L) | Control: 354 ± 9 | Sepsis: 265 ± 32 | TRAP assay | [31] |
 |  | Septic shock: 452 ± 34 |  |  |